2-bromothioanisole

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-bromothioanisole
• 英文别名: bromothioanisole；(2-Methoxyphenyl) thiohypobromite
• 化学式: C₇H₇BrOS
• 分子量: 219.102
• InChiKey: WUKFVPJVGIPEPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  34.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-bromothioanisole 在 碘 、 magnesium 、 三氯化砷 作用下， 以 四氢呋喃 为溶剂， 反应 18.0h， 以33%的产率得到tris(2-(methylthio)phenyl)arsane
  参考文献：
  名称：

  电子贫化环丙烷的羰基化C-C键活化：铑催化的（3 + 1 + 2）环丙基酰胺的环加成反应

  摘要：

  环丙基酰胺的Rh催化的羰基C-C键活化生成结构稳定的Rhodacyclopentanones，其与（3 + 1 + 2）环加成中的链状烯烃结合。这些研究提供了多组分环加成反应的第一个例子，该过程通过“简单的”电子贫乏的环丙烷的C-C键活化而进行。

  DOI：

  10.1002/anie.201811460
• 作为产物：
  描述：

  二(2-甲氧基苯基)二硫醚 在 溴 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 生成 2-bromothioanisole
  参考文献：
  名称：

  Design, synthesis and biological evaluation of sulfenimine cephalosporin sulfoxides as β-lactamase inhibitors

  摘要：

  A series of sulfenimine cephalosporin sulfoxide derivatives (7a-v) were designed, synthesized and evaluated for their inhibitory activity against TEM-1 and cephalosporinase in cell-free systems. Some of the tested compounds showed enhanced inhibitory activity against class C beta-lactamase cephalosporinase compared with the tazobactam. The most promising compounds 7c and 7n (IC50 = 7.6 and 8.6 mu mol/L, respectively) were further investigated in combination with cefradine against a variety of clinical isolated beta-lactamase-producing bacterial strains. (C) 2015 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.cclet.2015.04.025

文献信息

• Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
  申请人：Failli A. Amedeo

  公开号：US20060287522A1

  公开（公告）日：2006-12-21

  This invention provides pyrrolobenzodiazepine pyridine carboxamides selected from those of Formula (1), which act as follicle stimulating hormone receptor antagonists. The invention also provides pharmaceutical compositions and methods of treatment utilizing the compounds of Formulae (1) and (2).

  这项发明提供了从式（1）中选择的吡咯苯并二氮杂吡咯烷吡啶羧酰胺，其作为卵泡刺激素受体拮抗剂。该发明还提供了利用式（1）和（2）化合物的药物组合物和治疗方法。
• Novel piperidine compouds and drugs containing the same
  申请人：——

  公开号：US20030220368A1

  公开（公告）日：2003-11-27

  The present invention provides a novel compound having a superior Na + channel inhibition activity. Namely, it provides a compound represented by the following formula (I), a salt thereof or a hydrate of them. 1 In the formula, the ring A represents a ring represented by the formula: 2 (wherein R 1 represents a hydrogen atom etc.; and R 2 represents indicates a hydrogen atom and the like) etc.; W represents an optionally substituted C 1-6 alkylene group etc.; Z represents an optionally substituted C 6-14 aromatic hydrocarbon cyclic group etc.; and l represents an integer from 0 to 6.

  本发明提供了一种具有优越的Na + 通道抑制活性的新型化合物。即提供了由以下式（I）表示的化合物，其盐或其水合物。 在该式中，环A表示由以下式表示的环： （其中R 1 表示氢原子等；R 2 表示表示氢原子等）等；W表示可选地取代的C 1-6 烷基等；Z表示可选地取代的C 6-14 芳香烃环基等；l表示0到6的整数。
• 5-Substituted isoquinoline derivatives
  申请人：Yamada Rintaro

  公开号：US20050020623A1

  公开（公告）日：2005-01-27

  A compound represented by the following formula (1) or a salt thereof: wherein R 1 represents hydrogen atom, a halogen atom and the like; R 2 represents hydrogen atom, a halogen atom, a C 1-6 alkyl group and the like; and R 3 represents —O—X—C(A 1 )(A 11 )—C(A 2 )(A 2l )—N(A 3l )(A 3 )(X represents propylene group etc., A 11 and A 21 represent hydrogen atom, or a C 1-6 alkyl group, A 31 represents a C 1-6 alkyl group substituted with hydroxyl group, or hydrogen atom, and A 1 , A 2 , and A 3 represent hydrogen atom, a C 1-6 alkyl group and the like) and the like, which has an inhibitory activity on the phosphorylation of myosin regulatory light chain, and is useful for treatment of diseases relating to contraction of various cells and the like.

  由以下公式（1）表示的化合物或其盐： 其中R1代表氢原子、卤素原子等；R2代表氢原子、卤素原子、C1-6烷基团等；R3代表—O—X—C(A1)(A11)—C(A2)(A21)—N(A31)(A3)（X代表丙烯基等，A11和A21代表氢原子或C1-6烷基团，A31代表被羟基取代的C1-6烷基团或氢原子，A1、A2和A3代表氢原子、C1-6烷基团等）等，该化合物对肌球蛋白调节轻链的磷酸化具有抑制作用，并且对涉及各种细胞收缩等的疾病的治疗有益。
• Prostaglandin endoperoxide H synthase biosynthesis inhibitors
  申请人：Abbott Laboratories

  公开号：US06307047B1

  公开（公告）日：2001-10-23

  The present invention describes pyridazinone compounds of formula I which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important “housekeeping” enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectivity of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).

  该发明描述了式I的吡啶并酮化合物，这些化合物是环氧合酶（COX）抑制剂，特别是选择性地抑制环氧合酶-2（COX-2）。COX-2是与炎症相关的可诱导异构体，与构成性异构体环氧合酶-1（COX-1）相对，后者是许多组织中重要的“基础”酶，包括胃肠道（GI）和肾脏。这些化合物对COX-2的选择性减少了目前市售的非甾体类抗炎药（NSAIDs）所见到的不良胃肠道和肾脏副作用。
• Phenyl-isoxazoles as factor XA Inhibitors
  申请人：Dupont Pharmaceuticals Company

  公开号：US06187797B1

  公开（公告）日：2001-02-13

  The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(═NH)NH2, which are useful as inhibitors of factor Xa.

  本申请描述了氧和硫含杂芳烃及其衍生物的化学式，其中J为O或S，D可能为C(═NH)NH2，或其药用盐或前药形式，这些化合物可作为因子Xa的抑制剂。